Noga Brunicki
A graduate of both the Weizmann Institute of Science (Rehovot) and the Technion – Israel Institute of Technology (Haifa), Noga encompasses the very qualities that these highly-regarded Israeli academic institutions stand for: scientific excellence, integrity and determination.
With a flair for finding solutions where others see only a challenge, Noga is the driving force behind NovaTrials. It is her passion and commitment that has ensured that uncompromising quality and precision are built into the company’s DNA, alongside values of flexibility, creativity and problem solving.
Having spent more than 13 years working in the Israeli pharmaceutical, medical device, life science and health care industries, Noga’s expertise covers the entire development process. During her time at GlaxoSmithKline (GSK) Israel, prior to establishing NovaTrials CRO, she was involved in high-level, state-of-the-art clinical research, in a global team environment.
From early design and set-up of study plans, through monitoring and management, to wrapping up and reporting the results, Noga has the personal, hands-on experience that inspires confidence in NovaTrials’ clients. Reliably and efficiently supporting phase I-IV studies, for both medical device and medicinal products, in multiple therapeutic areas, she leverages her long-term strategic relationships with Israeli trial sites to integrate clinical studies into clinical routines.
